Reversible visual loss in a patient receiving high-dose ciprofloxacin hydrochloride (Cipro).
Publication/Presentation Date
6-1-1990
Abstract
Bilateral acute visual loss characterized by cecocentral scotomas and acquired dyschromatopsia developed in a patient receiving large oral doses of ciprofloxacin hydrochloride (Cipro). The visual defects improved after cessation of this antibiotic. To our knowledge, this association has not been described previously. The use of this medication in high doses must be accompanied by careful monitoring of optic nerve function.
Volume
97
Issue
6
First Page
707
Last Page
710
ISSN
0161-6420
Published In/Presented At
Vrabec, T. R., Sergott, R. C., Jaeger, E. A., Savino, P. J., & Bosley, T. M. (1990). Reversible visual loss in a patient receiving high-dose ciprofloxacin hydrochloride (Cipro). Ophthalmology, 97(6), 707–710. https://doi.org/10.1016/s0161-6420(90)32518-6
Disciplines
Medicine and Health Sciences
PubMedID
2374675
Department(s)
Department of Medicine
Document Type
Article